Saitama, Japan

Kimio Katsuda

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kimio Katsuda. Retrieved from https://idiyas.com/inventor/kimio-katsuda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kimio Katsuda: Innovator in Fatty Acid Derivatives

Introduction

Kimio Katsuda is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of fatty acid derivatives. His work has implications for various applications, especially in medical and pharmaceutical fields.

Latest Patents

Katsuda holds a patent for "Fatty acid derivatives and process of producing them." This invention includes fatty acid derivatives represented by a specific general formula and their salts. The compounds developed through this patent exhibit excellent fibrinolytic action and improved solubility, making them valuable in therapeutic applications.

Career Highlights

Katsuda is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in pharmaceutical formulations and has the potential to enhance treatment options for various health conditions.

Collaborations

Katsuda has collaborated with notable colleagues, including Shin-ichi Tsukamoto and Yoshinobu Nagano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kimio Katsuda's contributions to the field of fatty acid derivatives highlight his role as an important inventor in the pharmaceutical industry. His innovative work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…